Gains and Losses on Marketable Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Legal Matters and Contingencies Legal Matters and Contingencies [Text Block] North America Generics North America Generics [Member] North America Generics [Member] Number of restricted stock awards, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Consolidated Entities [Axis] Consolidated Entities [Axis] Taxes related to the net share settlement of equity awards Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Basic (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Receivable Type [Axis] Receivable Type [Axis] Accounts payable Disposal Group, Including Discontinued Operation, Other Liabilities, Current Dividends, Common Stock, Cash Dividends, Common Stock, Cash Security Exchange Name Security Exchange Name Weighted average grant-date fair value per share, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Yupelri ® Yupelri ® [Member] Yupelri ® Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Entity Address, Country Entity Address, Country Investment, Name [Axis] Investment, Name [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense 2023 Long-Term Debt, Maturity, Year Two Income taxes Increase (Decrease) in Income Taxes Payable Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes 2043 Senior Notes (5.400% coupon) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Other drug manufacturers Other Companies [Member] Other companies Fair Value Hedging Relationships Fair Value Hedging [Member] Percent Of Total Assets Impacted, High Inflationary Economy Percent Of Total Assets Impacted, High Inflationary Economy Percent Of Total Assets Impacted, High Inflationary Economy Subsequent Event Type [Domain] Subsequent Event Type [Domain] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Intangible asset amortization expense Amortization of Intangible Assets Amortization of Intangible Assets Defined Benefit Plans, Number of Frozen Plans Defined Benefit Plans, Number of Frozen Plans Defined Benefit Plans, Number of Frozen Plans Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Inventories Schedule of Inventory, Current [Table Text Block] Program Name [Axis] Program Name [Axis] Program Name Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Business Acquisition [Axis] Business Acquisition [Axis] Loss Contingency, Loss in Period Loss Contingency, Loss in Period Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Cash Flow Hedging Cash Flow Hedging [Member] North America Segment North America Segment [Member] North America Segment Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Additional cash payments to be received Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Judgment issued Damages awarded Loss Contingency, Damages Awarded, Value Retained Earnings Retained Earnings [Member] Retained Earnings [Member] Fair value of long-term debt Debt Instrument, Fair Value Disclosure 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Noncontrolling Interest, Ownership Percentage by Parent Noncontrolling Interest, Ownership Percentage by Parent Available-for-sale fixed income investments Debt Securities [Member] Accounts receivable Increase (Decrease) in Accounts Receivable Upjohn Inc. Upjohn Inc. [Member] Upjohn Inc. [Member] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Measurement Input, Estimated Tax Rate Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Basic (in USD per share) Basic earnings (loss) per share attributable to Viatris Inc. shareholders Earnings Per Share, Basic Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Number of restricted stock awards, nonvested beginning of period Number of restricted stock awards, nonvested end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2022 Long-Term Debt, Maturity, Year One Unamortized debt issuance expense Unamortized Debt Issuance Expense Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current Reporting Unit [Domain] Reporting Unit [Domain] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Employee benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Machinery and equipment Machinery and Equipment [Member] Commercial Paper [Member] Commercial Paper [Member] Other non-cash items Other Noncash Income (Expense) Fair value of financial instruments Derivative Asset, Fair Value, Gross Asset Business Combination [Abstract] Business Combination [Abstract] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Period [Domain] Period [Domain] [Domain] for Period [Axis] Other payables Accounts Payable, Other Trade receivables, net Receivables, Net, Current Term Loan Term Loan [Member] Term Loan Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Plan Name [Axis] Plan Name [Axis] Long-term debt Long-term Debt Other Liabilities, Other than Long-term Debt, Noncurrent Level 1 Fair Value, Inputs, Level 1 [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Cash, cash equivalents, and restricted cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Entity Small Business Entity Small Business Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Scenario [Axis] Scenario [Axis] Additional paid-in capital Additional Paid in Capital Intangible asset impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Number of equity method investments Number of equity method investments Number of equity method investments Interest rate swaps Interest Rate Swap [Member] Hedging Relationship [Domain] Hedging Relationship [Domain] 2026 Senior Notes (3.950% coupon) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Entity Interactive Data Current Entity Interactive Data Current Thereafter Long-Term Debt, Maturity, after Year Five 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Recognized net actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Tax related items, including contingencies Liability for Uncertainty in Income Taxes, Noncurrent Balance Sheet Location [Domain] Balance Sheet Location [Domain] Mylan Laboratories Limited Subsidiaries [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] 2019 Senior Notes (2.550% coupon) SeniorNotesTwoThousandNineteen [Member] Senior notes two thousand nineteen Entity Ordinary Shares, Shares Outstanding Entity Common Stock, Shares Outstanding Biocon Biologics Biocon Biologics [Member] Biocon Biologics Entity Address, State or Province Entity Address, State or Province Beginning Balance Ending Balance Restructuring Reserve Senior Notes 2022 Senior Notes 2022 [Member] Senior Notes 2022 Deferred income tax benefit Deferred Income Tax Assets, Net Current liabilities: Liabilities, Current [Abstract] Receivable [Domain] Receivable [Domain] Restructuring Plan [Domain] Restructuring Plan [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Accounting Policies [Abstract] Derivative Instruments Risk [Axis] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Average remaining contractual term for stock awards outstanding, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Document Transition Report Document Transition Report Common Stock, Value, Issued Common Stock, Value, Issued Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average grant-date fair value per share, nonvested beginning of period Weighted average grant-date fair value per share, nonvested end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Dividends payable (in dollars per share) Dividends Payable, Amount Per Share Rebates, promotional programs and other sales allowances Accrued Sales Allowances Accrued Sales Allowances 2020 Senior Notes (3.750% coupon) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent Acquisitions and Other Transactions Business Combination Disclosure [Text Block] Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Percent ownership after transaction Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2024 Euro Senior Notes 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Other Assets Schedule of Other Assets, Noncurrent [Table Text Block] Ownership [Axis] Ownership [Axis] Legal Entity [Axis] Legal Entity [Axis] Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Goodwill [Line Items] Goodwill [Line Items] Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition, Pro Forma Net Income (Loss) Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Term of transition services agreement Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement Income Tax Authority [Axis] Income Tax Authority [Axis] Work in process Inventory, Work in Process, Net of Reserves Multi District Litigation [Member] Multi District Litigation [Member] Multi District Litigation [Member] Senior Notes 2021 Senior Notes 2021 [Member] Senior Notes 2021 Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Entity [Domain] Entity [Domain] Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Net sales Sales Revenue, Goods, Net Revenue from Contract with Customer, Excluding Assessed Tax Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Finished goods Inventory, Finished Goods, Net of Reserves Corporate costs Corporate costs Corporate costs Consolidated Entity Consolidated Entity, Excluding VIE [Member] Stock awards Share-based Payment Arrangement, Option [Member] Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Document Quarterly Report Document Quarterly Report Measurement Input Type [Domain] Measurement Input Type [Domain] JANZ Rest of World Segment [Member] Rest of World Segment Prepaid Expense and Other Assets [Abstract] Prepaid Expense and Other Assets [Abstract] Variable Rate [Axis] Variable Rate [Axis] Segment Information Segment Reporting Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] 2024 Euro Senior Notes, 1.023% 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Trailing Four Quarters [Member] Trailing Four Quarters [Member] Trailing Four Quarters Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Variable Rate [Domain] Variable Rate [Domain] Additional Paid-In Capital Additional Paid-in Capital [Member] Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Net unrecognized gains (losses) on derivatives, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Dividends paid (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Generics Generics [Member] Generics Goodwill, Transfers Goodwill, Transfers Other expense, net Other Nonoperating Income (Expense) Pension and other postretirement benefits Other Pension, Postretirement and Supplemental Plans [Member] Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Business Combinations [Abstract] Business Combinations [Abstract] Maximum Maximum [Member] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Raw materials Inventory, Raw Materials, Net of Reserves Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Restructuring and Related Cost, Expected Cost Remaining Restructuring and Related Cost, Expected Cost Remaining City Area Code City Area Code Restricted cash Restricted Cash and Cash Equivalents, Current Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Viatris Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Number of states Number of states Number of states Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets U.K. Competition and Markets Authority Proceedings Paroxetine U.K. Competition and Markets Authority Proceedings Paroxetine [Member] U.K. Competition and Markets Authority Proceedings Paroxetine Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Net unrecognized losses and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Operating Segment Operating Segments [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Restricted stock awards Restricted Stock Units (RSUs) [Member] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Other Other Long Term Debt [Member] Other long term debt. Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Asset Class [Domain] Asset Class [Domain] Number of Countries in which Entity Operates Number of Countries in which Entity Operates Diluted (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income tax (benefit) provision Income Tax Expense (Benefit) Income Tax Expense (Benefit) Accounts receivable, net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Entity Tax Identification Number Entity Tax Identification Number Basic (in shares) Weighted Average Basic Shares Outstanding, Pro Forma Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets Other comprehensive loss, before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Trade accounts payable Accounts Payable, Trade Number of restricted stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Current portion of long-term debt and other long-term obligations Long-term Debt, Current Maturities Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Lyrica ® Lyrica ® [Member] Lyrica ® Restructuring Plan [Axis] Restructuring Plan [Axis] Pfizer, Inc. Pfizer, Inc. [Member] Pfizer, Inc. [Member] Equity Component [Domain] Equity Component [Domain] Disposal Group Name [Domain] Disposal Group Name [Domain] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Line of Credit Facility, Covenant Terms Line of Credit Facility, Covenant Terms Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Litigation Case [Axis] Litigation Case [Axis] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Zoloft ® Zoloft ® [Member] Zoloft ® 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Utilization Restructuring and Related Cost, Incurred Cost Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Liabilities Liabilities [Abstract] Equivalent percentage of redeemed amount Equivalent Price Percentage Of Principal Amount Redeemable Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date. Counterparty Name [Domain] Counterparty Name [Domain] Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Purchase of marketable securities Payments to Acquire Marketable Securities Measurement Input, Long-term Revenue Growth Rate Measurement Input, Long-term Revenue Growth Rate [Member] Earnings before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Level 2 Fair Value, Inputs, Level 2 [Member] Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Type of Restructuring [Domain] Type of Restructuring [Domain] Segment Reporting [Abstract] Segment Reporting [Abstract] Finite-lived intangible assets, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life TURKEY TURKEY Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Antitrust Proceedings Antitrust Proceedings [Member] Antitrust proceedings Title of 12(b) Security Title of 12(b) Security Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Investment, Name [Domain] Investment, Name [Domain] Payments to Noncontrolling Interests Payments to Noncontrolling Interests Ordinary shares, shares authorized Common Stock, Shares Authorized Short-term Debt [Abstract] Short-term Debt [Abstract] Net earnings (loss) Net earnings (loss) attributable to Viatris Inc. common shareholders Net earnings (loss) Net Income (Loss) Available to Common Stockholders, Basic Document Type Document Type Product and Service [Domain] Product and Service [Domain] Fair value loss Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Stated percentage rate Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Revolving Credit Facility Revolving Credit Facility [Member] 2023 Senior Notes (4.200% coupon) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent Corporate Bond Securities [Member] Corporate Bond Securities [Member] Geographical [Axis] Geographical [Axis] Proceeds from sale of terminated interest rate swaps Proceeds from Sale of Securities, Operating Activities Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Product Product [Member] Net Investment Hedging Net Investment Hedging [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Interest Expense [Member] Interest Expense [Member] Amortization of prior service costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities 2019 Senior Notes (2.500% coupon) SeniorNotesTwoThousandNineteen2.50Precent [Member] 2019 Senior Notes (2.500%) Contingent consideration Contingent Consideration [Member] Contingent Consideration. Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Upfront payment subject to certain adjustments Disposal Group, Including Discontinued Operation, Cash Stock option award vesting period, in years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Variable Consideration Variable Consideration [Member] Variable Consideration [Member] 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Loss from equity method investments Income (Loss) from Equity Method Investments Exchange traded funds Exchange Traded Funds [Member] Nonvested Restricted Stock and Restricted Stock Unit Awards Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Period [Axis] Period [Axis] Period [Axis] Charges Restructuring Charges 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Foreign Tax Authority Foreign Tax Authority [Member] Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Derivative [Table] Derivative [Table] Document Period End Date Document Period End Date Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Proceeds from sale and collection of receivables Proceeds from Sale and Collection of Receivables Consolidated Entities [Domain] Consolidated Entities [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Complex GX and Biosimilars Complex GX and Biosimilars [Member] Complex GX and Biosimilars Emerging Markets Emerging Markets Segment [Member] Emerging Markets Segment Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Greater China Greater China Segment [Member] Greater China Segment Receivables Facility Receivables Facility [Member] Receivables facility. Income Statement Location [Domain] Income Statement Location [Domain] Medicaid and other governmental rebates Medicaid and other governmental rebates Medicaid and other governmental rebates Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Total operating expenses Operating Expenses Land and improvements Land and Land Improvements [Member] Expected Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Payments of long-term debt Repayments of Long-term Debt Earnings (loss) per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Earnings Per Share [Abstract] Collaborative Arrangement Collaborative Arrangement [Member] Equity method investments summarized financial data basis Equity Method Investments Summarized Financial Data Basis Equity Method Investments Summarized Financial Data Basis Property, plant and equipment, gross Property, Plant and Equipment, Gross Total revenues Revenues Revenues Other Liabilities, Fair Value Disclosure Other Liabilities, Fair Value Disclosure Foreign currency forward contracts Foreign currency borrowings and forward contracts Foreign Exchange Contract [Member] Loss Contingency Accrual Loss Contingency Accrual 2022 Euro Senior Notes 2022 Euro Senior Notes [Member] 2022 Euro Senior Notes Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Patents and technologies Patents [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Entity Current Reporting Status Entity Current Reporting Status Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Other Other Debt Obligations [Member] Current portion of long-term debt Debt, Current Counterparty Name [Axis] Counterparty Name [Axis] Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Dymista ® Dymista ® [Member] Dymista ® Balance (in shares) Balance (in shares) Shares, Issued Dividends Dividends Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Expected reduction to tax expense by CARES Act Effective Income Tax Rate Reconciliation, CARES Act, Amount Effective Income Tax Rate Reconciliation, CARES Act, Amount Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Common Stock, Capital Shares Reserved for Future Issuance Common Stock, Capital Shares Reserved for Future Issuance London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Accounts payable Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Diluted Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Total intangible asset amortization expense (including impairment charges) Amortization Income Taxes Income Tax Disclosure [Text Block] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Country Region Country Region Stock Awards Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] 2018 Senior Notes (2.600% coupon) Senior Notes Two Thousand Eighteen - 2.6 Percent [Member] Senior Notes Two Thousand Eighteen - 2.6% [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input 2020 Floating Rate Euro Notes 2020 Floating Rate Euro Notes [Member] 2020 Floating Rate Euro Notes Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Restructuring Reserve, Noncurrent Restructuring Reserve, Noncurrent Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Entity Shell Company Entity Shell Company Schedule of Short-term Debt Schedule of Short-term Debt [Table Text Block] Total current liabilities Liabilities, Current Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Foreign exchange forward contracts Foreign Exchange Forward [Member] Money market funds Money Market Funds [Member] Accounts payable Accounts payable Accounts Payable, Trade, Current Loss Contingencies [Table] Loss Contingencies [Table] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Current Fiscal Year End Date Current Fiscal Year End Date Financial Instruments and Risk Management Financial Instruments Disclosure [Text Block] Number of defendants Loss Contingency, Number of Defendants Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Long-Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Percent Of Net Sales Impacted, High Inflationary Economy Percent Of Consolidated Net Sales Impacted, High Inflationary Economy Percent Of Consolidated Net Sales Impacted, High Inflationary Economy Statement [Table] Statement [Table] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Total unrecognized compensation expense, net of estimated forfeitures Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Range [Axis] Statistical Measurement [Axis] Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Subsequent Event Subsequent Event [Member] Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net Goodwill Goodwill Goodwill, net, beginning balance Goodwill, net, ending balance Goodwill Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Scenario, Unspecified [Domain] Scenario [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Defined Benefit Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Average remaining contractual term for stock awards vested and expected to vest, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Xalabrands Xalabrands [Member] Xalabrands Australian Taxation Office Australian Taxation Office [Member] Deferred income tax benefit Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Hedging Designation [Domain] Hedging Designation [Domain] Share repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Long-term debt and other noncurrent obligations Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Goodwill Disposal Group, Including Discontinued Operation, Goodwill Earnings per Share Policy Earnings Per Share, Policy [Policy Text Block] Accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Payroll and employee benefit liabilities Employee-related Liabilities, Current Interest cost Defined Benefit Plan, Interest Cost Income Statement Location [Axis] Income Statement Location [Axis] Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Range [Domain] Statistical Measurement [Domain] European Commission Proceedings - Perindorpril EU Commission Proceedings Perindorpril [Member] EU Commission Proceedings Perindorpril Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Segment Reporting Policy Segment Reporting, Policy [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Restructuring Type [Axis] Restructuring Type [Axis] Other assets Other assets Other Assets, Noncurrent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Segments [Axis] Segments [Axis] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Entity File Number Entity File Number 2021 Senior Notes (3.150% coupon) SeniorNotesTwoThousandTwentyOne3.15Precent [Member] 2021 Senior Notes 3.15% Stock compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Net unrecognized gain (loss) on derivatives Net unrecognized losses on derivatives in net investment hedging relationships, net of tax Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent Viagra ® Viagra ® [Member] Viagra ® Effect on Future Cash Flows, Amount Effect on Future Cash Flows, Amount Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Payments of financing fees Payments of Financing Costs Clean Energy Partnerships [Member] Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Liability Class [Axis] Liability Class [Axis] Building Building [Member] EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Weighted average grant-date fair value per share, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Disposal Group Name [Axis] Disposal Group Name [Axis] Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] ASSETS Assets [Abstract] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill 2024 Long-Term Debt, Maturity, Year Three Accumulated impairment losses, beginning balance Accumulated impairment losses, ending balance Goodwill, Impaired, Accumulated Impairment Loss Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Reconciling items: Segment Reconciling Items [Member] Number of restricted stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Debt Instrument [Axis] Debt Instrument [Axis] Contingencies Commitments and Contingencies Disclosure [Text Block] Series of Individually Immaterial Business Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Business Combination, Contingent Consideration, Liability, Measurement Input Business Combination, Contingent Consideration, Liability, Measurement Input Finite-Lived Intangible Assets Finite-Lived Intangible Assets [Member] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Other comprehensive loss, before tax Other comprehensive loss, before tax Other Comprehensive Income (Loss), before Tax Unusual Risk or Uncertainty [Table] Unusual Risk or Uncertainty [Table] Prepaid expenses Prepaid Expense, Current Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] 2026 Long-Term Debt, Maturity, Year Five Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Ordinary shares reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Number of cases Number of cases Number of cases JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Equity securities Debt Securities, Trading, and Equity Securities, FV-NI Total Long-term Debt, Gross Goodwill [Roll Forward] Goodwill [Roll Forward] Reporting Unit [Axis] Reporting Unit [Axis] Total assets at recurring fair value measurement Assets, Fair Value Disclosure Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Total liabilities and equity Liabilities and Equity Other Other Accrued Liabilities, Current Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member] Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2048 Senior Notes (5.200%) SeniorNotesTwoThousandFortyEight [Member] SeniorNotesTwoThousandFortyEight [Member] 2.125% Euro Senior Notes due 2025 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Income Tax Contingency [Table] Income Tax Contingency [Table] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Intangible assets, net Disposal Group, Including Discontinued Operation, Intangible Assets Earnings (Loss) per Ordinary Share Earnings Per Share [Text Block] Assets held for sale Disposal Group, Including Discontinued Operation, Assets Operating expenses: Operating Expenses [Abstract] Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Minimum Minimum [Member] Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Note Securitization Facility Note Securitization Facility [Member] Note Securitization Facility [Member] Gross profit Gross loss Gross Profit Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] Financial and Nonfinancial Liabilities, Fair Value Disclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure Selling, general and administrative Selling, General and Administrative Expense Proceeds from the sale of assets Proceeds from Sale of Productive Assets Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Influvac ® Influvac ® [Member] Influvac ® Foreign currency translation Restructuring Reserve, Translation and Other Adjustment Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired North America Brands North America Brands [Member] North America Brands [Member] 2025 Long-Term Debt, Maturity, Year Four Cash paid for acquisitions, net Payments to Acquire Businesses, Net of Cash Acquired Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Debt Debt Disclosure [Text Block] Other Exit Costs Other Restructuring [Member] Line of Credit [Member] Line of Credit [Member] Share-Based Incentive Plan Share-based Payment Arrangement [Text Block] Senior Notes Senior Notes [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Net unrealized gain on marketable securities, net of tax Net unrealized gain (loss) on marketable securities, net of tax, beginning of period Net unrealized gain (loss) on marketable securities, net of tax, end of period AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Basis of Accounting Policy Basis of Accounting, Policy [Policy Text Block] Accumulated other comprehensive loss Accumulated other comprehensive loss, net of tax, beginning of period Accumulated other comprehensive loss, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt Disposal Group Classification [Axis] Disposal Group Classification [Axis] Cover [Abstract] Cover [Abstract] Diluted (in shares) Pro Forma Weighted Average Shares Outstanding, Diluted Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Treasury stock, shares Balance (in shares) Balance (in shares) Treasury Stock, Shares Unusual Risk or Uncertainty [Line Items] Unusual Risk or Uncertainty [Line Items] Short-term Debt [Line Items] Short-term Debt [Line Items] Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Revenue Not from Contract with Customer Revenue Not from Contract with Customer Net unrealized loss on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent Cash payment Payments for Restructuring Common Stock Marketable securities Common Stock [Member] Earnings (loss) from operations Operating Income (Loss) 2018 Senior Notes (3.000% coupon) Senior Notes Two Thousand Eighteen - 3.0 Percent [Member] Senior Notes Two Thousand Eighteen - 3.0 Percent Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Operating lease liability Operating Lease, Liability, Current Collaboration and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Hedging Designation [Axis] Hedging Designation [Axis] Foreign currency translation adjustment Foreign currency translation adjustment, beginning of period Foreign currency translation adjustment, end of period Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Share-based Compensation Share-based Payment Arrangement, Noncash Expense Restructuring Restructuring and Related Activities Disclosure [Text Block] Inventories Disposal Group, Including Discontinued Operation, Inventory, Current Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value 2046 Senior Notes (5.250% coupon) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Treasury Stock Treasury Stock [Member] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment Other current liabilities Equity method investments, clean energy investments Other Liabilities, Current Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Total liabilities Liabilities 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Measurement Input Type [Axis] Measurement Input Type [Axis] Consolidation Items [Axis] Consolidation Items [Axis] Creon ® Creon ® [Member] Creon ® Change in unrecognized (loss) gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Change in unrecognized gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Entity Address, City or Town Entity Address, City or Town EpiPen Auto Injector Civil Litigation [Member] EpiPen Auto Injector Civil Litigation [Member] EpiPen Auto Injector Civil Litigation [Member] Current Portion of Long-Term Debt Current Portion of Long-Term Debt [Member] Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Interest expense Interest Expense Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Retained earnings Retained Earnings (Accumulated Deficit) Litigation Case Type [Domain] Litigation Case [Domain] Stock option award expiration period, in years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Contingent consideration payments Payments of Merger Related Costs, Financing Activities Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Equity Method Investments Equity Method Investments [Table Text Block] Entity Filler Category Entity Filer Category Developed Markets Developed Markets Segment [Member] Developed Markets Segment Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] U.S. Treasuries US Treasury Securities [Member] Modafinil Antitrust Litigation and FTC Inquiry Modafinil Antitrust Litigation and FTC Inquiry [Member] Modafinil Antitrust Litigation and FTC Inquiry. Celebrex ® Celebrex ® [Member] Celebrex ® 2028 Senior Notes [Member] 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] New Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Accretion expense Accretion Expense In-process research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Proceeds from exercise of stock options Proceeds from Stock Options Exercised Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Total equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Amendment Flag Amendment Flag Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Unusual or Infrequent Item, or Both Unusual or Infrequent Item, or Both [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Gains and Losses on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Inventories Inventories Inventory, Net Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] European Union Commission Proceedings - Citalopram EU Commission Proceedings Citalopram [Member] EU Commission Proceedings Citalopram Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Product and Service [Axis] Product and Service [Axis] Biosimilars Portfolio Biosimilars Portfolio [Member] Biosimilars Portfolio Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Statement [Line Items] Statement [Line Items] Current assets (excluding inventories and net of cash acquired) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Retirement Plan Type [Domain] Retirement Plan Type [Domain] YEN Term Loan YEN Term Loan [Member] YEN Term Loan Available-for-sale securities Debt Securities, Available-for-sale Debt Disclosure [Abstract] Debt Disclosure [Abstract] Chargebacks Chargebacks Chargebacks Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Corporate / Other Corporate, Non-Segment [Member] Revenue of biosimilars portfolio Disposal Group, Including Discontinued Operation, Revenue Other expense Other Expense [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Pension and Other Postretirement Benefits Disclosure Retirement Benefits [Text Block] Accounts payable Increase (Decrease) in Accounts Payable, Trade Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Asset Class [Axis] Asset Class [Axis] Scenario, Forecast Forecast [Member] Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Program Name [Domain] Program Name [Domain] [Domain] for Program Name Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Total assets Assets Income tax provision Other Comprehensive Income (Loss), Tax Litigation settlements and other contingencies, net Litigation settlements and other contingencies, net Gain (Loss) Related to Litigation Settlement EpiPen Auto-Injector Litigation EpiPen Auto-Injector Litigation [Member] EpiPen Auto-Injector Litigation Plan Name [Domain] Plan Name [Domain] Geographical [Domain] Geographical [Domain] Mylan N.V. Mylan Parent Company [Member] Research and development Research and development Research and Development Expense Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Derivative Contract Type [Domain] Derivative Contract [Domain] Other long-term assets Other long-term assets Other long-term assets Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Short-term borrowings Short-term Debt Revenue Recognition And Accounts Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Summary of Long-Term Debt Schedule of Debt [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Other assets Disposal Group, Including Discontinued Operation, Other Assets Other receivables Other Receivables, Net, Current Corporate and Other Corporate and Other [Member] Basic Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Basic Diluted (in USD per share) Diluted earnings (loss) per ordinary share Earnings Per Share, Diluted Segments [Domain] Segments [Domain] Service cost Defined Benefit Plan, Service Cost Damages to be paid Loss Contingency, Damages Paid, Value Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Sales [Member] Sales [Member] Xanax ® Xanax ® [Member] Xanax ® Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Finite-lived Intangible Assets Amortization Expense Finite-lived Intangible Assets Amortization Expense [Table Text Block] Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Comprehensive earnings (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Employee Related Costs Employee Severance [Member] Restructuring Restructuring Reserve, Current Restructuring and Related Cost, Expected Number of Positions Eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Deferred income tax liability Deferred Income Tax Liabilities, Net Other long-term obligations Other Noncurrent Liabilities [Member] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes Depreciation and amortization Depreciation, Depletion and Amortization Measurement Input, Control Premium Measurement Input, Control Premium [Member] Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] 2022 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Inventories Increase (Decrease) in Inventories Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Restructuring - employee related Restructuring and Related Costs [Table Text Block] Cost of sales Cost of Goods and Services Sold Estimated employer contributions in current year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Entity Central Index Key Entity Central Index Key Other Revenues Product and Service, Other [Member] Amitiza ® Amitiza ® [Member] Amitiza ® Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Other long-term obligations Other Liabilities, Noncurrent Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Interest rate swap derivative assets Derivative Asset Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Revenue AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Other Current Liabilities [Member] Other current liabilities Other Current Liabilities [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Issuance of restricted stock, net of shares withheld Restricted Stock, Value, Shares Issued Net of Tax Withholdings Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Goodwill, gross, beginning balance Goodwill, gross, ending balance Goodwill, Gross Lipitor Lipitor ® [Member] Lipitor ® Long-term debt Long-term Debt, Excluding Current Maturities Schedule of Goodwill [Table] Schedule of Goodwill [Table] EpiPen Israeli Securities Litigation [Member] EpiPen Israeli Securities Litigation [Member] EpiPen Israeli Securities Litigation [Member] Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Average remaining contractual term for stock awards exercisable, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Other Litigation Other [Member] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Brands Brands [Member] Brands Construction in progress Construction in Progress [Member] Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common Stock, Par or Stated Value Per Share Ordinary shares, nominal value Common Stock, Par or Stated Value Per Share Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Measurement Input, EBITDA Multiple Measurement Input, EBITDA Multiple [Member] Current assets: Assets, Current [Abstract] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Other items, net Proceeds from (Payments for) Other Financing Activities Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Number Of Products Number Of Products Number Of Products Components of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Business Combination Contingent Consideration Liability Payments Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Other comprehensive loss, net of tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Estimated litigation liability Estimated Litigation Liability Accrued interest Interest Payable, Current Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Payments for Business Separation Payments for Business Separation Payments for Business Separation Reduction due to lapse in statues Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Fair Value of Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Product Liability Product Liability [Member] Product Liability Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Buildings and improvements Building and Building Improvements [Member] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Issuance of restricted stock, net of shares withheld (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Notional amount of derivative Derivative Asset, Notional Amount Greater China Europe Segment [Member] Europe Segment Weighted average grant-date fair value per share, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Effexor ® Effexor ® [Member] Effexor ® Norvasc Norvasc ® [Member] Norvasc ® Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Ownership [Domain] Ownership [Domain] Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other current assets Other Assets, Current Asset-backed Securities Asset-backed Securities [Member] Assets held for sale Assets Held-for-sale, Not Part of Disposal Group, Current Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Fair value of financial instruments Derivative Liability, Fair Value, Gross Liability Income taxes payable Accrued Income Taxes, Current 2016 Revolving Credit Facility 2016 Senior Revolving Credit Facility [Member] 2016 Senior Revolving Credit Facility [Member] Intellectual Property Developed Technology Rights [Member] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] 2048 Senior Notes [Member] 2048 Senior Notes [Member] 2048 Senior Notes [Member]